Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.

International journal of molecular medicine - 1 Aug 2004

Akbar S M F, Furukawa Shinya, Hasebe Aki, Horiike Norio, Michitaka Kojiro, Onji Morikazu

Abstract excerpt

Recently a new field of immunological research and clinical application of vaccines for therapeutic purposes (vaccine therapy) has been developed for treating several chronic viral infections including chronic hepatitis B virus (HBV) infection. Administration of vaccine containing hepatitis B surface antigen (HBsAg) for 1 year has resulted in negative HBsAg and development of antibody to HBsAg (anti-HBs) in some,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Centrifugation, Density Gradient
Share to Collagenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Hepatitis B Vaccines

Share to Immune Tolerance

Share to Immunotherapy

Share to Vaccination

Share to Vaccines

Source

Identifiers

PMID: 15254781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.PMID 15254781Read ↗

Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.Semantic proximity Read ↗

Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.Semantic proximity Read ↗

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.Semantic proximity Read ↗

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.Semantic proximity Read ↗

Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign EpitopesSemantic proximity Read ↗

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.Semantic proximity Read ↗

Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.Semantic proximity Read ↗

Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.Semantic proximity Read ↗

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.Semantic proximity Read ↗

Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.